Search research articles
Contact Us
Filters
Showing results (111-120 of 181) with videos related to
Page
of 19
Sort By:
Ugeskrift for Laeger
|
October 1, 2021
[New hereditary polyposis syndromes in the patient with intestinal polyps]
Anne Marie Jelsig, Niels Jespersen, John Gásdal Karstensen, et al.
Journal of the Neurological Sciences
|
May 21, 2025
Virus-specific antibody responses in multiple sclerosis patients treated with Ocrevus
Nadia Zivlaei, Daut Can Asani, Nicole Hartwig Trier, et al.
Clinical Genetics
|
April 12, 2024
Expanding the understanding of telomere biology disorder with reports from two families harboring variants in ZCCHC8 and TERC
Nikolaj Juul Nitschke, Anne Marie Jelsig, Charlotte Lautrup, et al.
Frontiers in Neuroscience
|
April 4, 2025
Insights from DCE-MRI: blood-brain barrier permeability in the context of MS relapses and methylprednisolone treatment
Stig P Cramer, Nizar Hamrouni, Helle J Simonsen, et al.
Nature
|
December 20, 2023
Minute-scale oscillatory sequences in medial entorhinal cortex
Soledad Gonzalo Cogno, Horst A Obenhaus, Ane Lautrup, et al.
European Journal of Medical Genetics
|
October 16, 2012
Heart defects and other features of the 22q11 distal deletion syndrome
Christina R Fagerberg, Jesper Graakjaer, Ulrike D Heinl, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
June 16, 2025
Blood-brain barrier permeability in relation to disease severity and timing of multiple sclerosis diagnosis in optic neuritis
Moschoula Passali, Maria Højberg Knudsen, Knud Josefsen, et al.
Lancet (London, England)
|
October 22, 2003
Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis
Per Soelberg Sorensen, Christian Ross, Katja Maria Clemmesen, et al.
The Lancet. Neurology
|
July 12, 2011
Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial
Per Soelberg Sorensen, Jan Lycke, Juha-Pekka Erälinna, et al.
Ugeskrift for Laeger
|
August 12, 2022
[Telomere biology disorders]
Anna Byrjalsen, Anette Bygum, Charlotte Kvist Lautrup, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 181) with videos related to
Sort By:
Page
of 19
Ugeskrift for Laeger
|
October 1, 2021
[New hereditary polyposis syndromes in the patient with intestinal polyps]
Anne Marie Jelsig, Niels Jespersen, John Gásdal Karstensen, et al.
Journal of the Neurological Sciences
|
May 21, 2025
Virus-specific antibody responses in multiple sclerosis patients treated with Ocrevus
Nadia Zivlaei, Daut Can Asani, Nicole Hartwig Trier, et al.
Clinical Genetics
|
April 12, 2024
Expanding the understanding of telomere biology disorder with reports from two families harboring variants in ZCCHC8 and TERC
Nikolaj Juul Nitschke, Anne Marie Jelsig, Charlotte Lautrup, et al.
Frontiers in Neuroscience
|
April 4, 2025
Insights from DCE-MRI: blood-brain barrier permeability in the context of MS relapses and methylprednisolone treatment
Stig P Cramer, Nizar Hamrouni, Helle J Simonsen, et al.
Nature
|
December 20, 2023
Minute-scale oscillatory sequences in medial entorhinal cortex
Soledad Gonzalo Cogno, Horst A Obenhaus, Ane Lautrup, et al.
European Journal of Medical Genetics
|
October 16, 2012
Heart defects and other features of the 22q11 distal deletion syndrome
Christina R Fagerberg, Jesper Graakjaer, Ulrike D Heinl, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
June 16, 2025
Blood-brain barrier permeability in relation to disease severity and timing of multiple sclerosis diagnosis in optic neuritis
Moschoula Passali, Maria Højberg Knudsen, Knud Josefsen, et al.
Lancet (London, England)
|
October 22, 2003
Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis
Per Soelberg Sorensen, Christian Ross, Katja Maria Clemmesen, et al.
The Lancet. Neurology
|
July 12, 2011
Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial
Per Soelberg Sorensen, Jan Lycke, Juha-Pekka Erälinna, et al.
Ugeskrift for Laeger
|
August 12, 2022
[Telomere biology disorders]
Anna Byrjalsen, Anette Bygum, Charlotte Kvist Lautrup, et al.
Page
of 19